Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery

Journal of Controlled Release

Volumn 136, Issue 2, 2009, Pages 140-147

  Higashi, Tomoko ^a,b   Khalil, Ikramy A ^a,b   Maiti, Kaustabh K ^c   Lee, Woo Sirl ^c   Akita, Hidetaka ^a,b   Harashima, Hideyoshi ^a,b   Chung, Sung Kee ^c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Condensation; Guanidine; MEND; Non viral gene delivery; Octaarginine; Sorbitol

Indexed keywords

GUANIDINE; MEND; NON-VIRAL GENE DELIVERY; OCTAARGININE; SORBITOL;

ALCOHOLS; AMINES; AMINO ACIDS; CONDENSATION; DNA; GENES; LIGANDS; NUCLEIC ACIDS;

GENE TRANSFER;

ARGININE; DRUG CARRIER; GUANIDINE; LIPOFECTIN; PLASMID DNA; SMALL INTERFERING RNA; SORBITOL;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG UPTAKE; HELA CELL; HUMAN; HUMAN CELL; LIPID VESICLE; MOUSE; MULTIFUNCTIONAL ENVELOPE TYPE NANODEVICE; NANODEVICE; NANOENCAPSULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

ANIMALS; CHICKENS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; LIPIDS; MICE; NIH 3T3 CELLS; SORBITOL;

EID: 67349102019     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.01.024     Document Type: Article

References (27)

1. Williams D.A., and Baum C. Medicine. Gene therapy-new challenges ahead. Science (New York, N.Y.) 302 5644 (2003) 400-401
2. Kaiser J. Gene therapy. Putting the fingers on gene repair. Science (New York, N.Y.) 310 5756 (2005) 1894-1896
3. Kostarelos K., and Miller A.D. Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chemical Society Reviews 34 11 (2005) 970-994
4. Mastrobattista E., van der Aa M.A., Hennink W.E., and Crommelin D.J. Artificial viruses: a nanotechnological approach to gene delivery. Nature Reviews 5 2 (2006) 115-121
5. Gius D.R., Ezhevsky S.A., Becker-Hapak M., Nagahara H., Wei M.C., and Dowdy S.F. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Research 59 11 (1999) 2577-2580
6. Yuan J., Kramer A., Eckerdt F., Kaufmann M., and Strebhardt K. Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation. Cancer Research 62 15 (2002) 4186-4190
7. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicines 10 3 (2004) 310-315
8. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., Takehashi M., Tanaka S., Ueda K., Simpson J.C., Jones A.T., Sugiura Y., and Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Molecular Therapy 10 6 (2004) 1011-1022
9. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., Harashima H., and Sugiura Y. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjugate Chemistry 12 6 (2001) 1005-1011
10. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., and D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proceedings of the National Academy of Sciences of the United States of America 100 4 (2003) 1972-1977
11. Rudolph C., Plank C., Lausier J., Schillinger U., Muller R.H., and Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. The Journal of Biological Chemistry 278 13 (2003) 11,411-11,418
12. Hyndman L., Lemoine J.L., Huang L., Porteous D.J., Boyd A.C., and Nan X. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. Journal of Controlled Release 99 3 (2004) 435-444
13. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., and Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. Journal of Controlled Release 98 2 (2004) 317-323
14. Khalil I.A., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., and Harashima H. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Therapy 11 7 (2004) 636-644
15. Khalil I.A., Kogure K., Futaki S., and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. The Journal of Biological Chemistry 281 6 (2006) 3544-3551
16. Khalil I.A., Kogure K., Futaki S., Hama S., Akita H., Ueno M., Kishida H., Kudoh M., Mishina Y., Kataoka K., Yamada M., and Harashima H. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Therapy 14 8 (2007) 682-689
17. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proceedings of the National Academy of Sciences of the United States of America 97 24 (2000) 13,003-13,008
18. Wender P.A., Rothbard J.B., Jessop T.C., Kreider E.L., and Wylie B.L. Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. Journal of the American Chemical Society 124 45 (2002) 13,382-13,383
19. Zhou P., Wang M., Du L., Fisher G.W., Waggoner A., and Ly D.H. Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA). Journal of the American Chemical Society 125 23 (2003) 6878-6879
20. Maiti K.K., Jeon O.Y., Lee W.S., Kim D.C., Kim K.T., Takeuchi T., Futaki S., and Chung S.K. Design, synthesis, and membrane-translocation studies of inositol-based transporters. Angewandte Chemie (International ed.) 45 18 (2006) 2907-2912
21. Maiti K.K., Lee W.S., Takeuchi T., Watkins C., Fretz M., Kim D.C., Futaki S., Jones A., Kim K.T., and Chung S.K. Guanidine-containing molecular transporters: sorbitol-based transporters show high intracellular selectivity toward mitochondria. Angewandte Chemie. International Edition 46 31 (2007) 5880-5884
22. Maiti K.K., Jeon O.Y., Lee W.S., and Chung S.K. Design, synthesis, and delivery properties of novel guanidine-containing molecular transporters built on dimeric inositol scaffolds. Chemistry European Journal (Weinheim an der Bergstrasse, Germany) 13 3 (2007) 762-775
23. Moriguchi R., Kogure K., Akita H., Futaki S., Miyagishi M., Taira K., and Harashima H. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. International Journal of Pharmaceutics 301 1-2 (2005) 277-285
24. Khalil I.A., Kogure K., Futaki S., and Harashima H. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. International Journal of Pharmaceutics 354 1-2 (2008) 39-48
25. Nakamura Y., Kogure K., Futaki S., and Harashima H. Octaarginine-modified multifunctional envelope-type nano device for siRNA. Journal of Controlled Release 119 3 (2007) 360-367
26. Hama S., Akita H., Ito R., Mizuguchi H., Hayakawa T., and Harashima H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Molecular Theraphy 13 4 (2006) 786-794
27. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., Takehashi M., Tanaka S., Ueda K., Simpson J.C., Jones A.T., Sugiura Y., and Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Molecular Theraphy 10 6 (2004) 1011-1022